Creating regional recovery hubs in Indiana’s mental health ‘deserts’ Mental health touches all of us, our friends, our families, ourselves. And with the CDC recently reporting an all-time high suicide rate, it’s never been more important to let people know that help is available. Learn more
Indiana health officials warn about ’emerging threat’ of drug Bromazolam Indiana health officials warn about ’emerging threat’ of drug Bromazolam. Learn more
Mental Health America of Indiana Receives $900,000 Grant from Anthem Blue Cross and Blue Shield Foundation During “Mental Health Matters Day” at the Indiana State Fair Mental Health America of Indiana (MHAI) announced today a 3-year, $900,000 grant from Anthem Blue Cross and Blue Shield Foundation during “Mental Health Matters Day” at the Indiana State Fair. Representatives from Anthem Blue Cross and Blue Shield Foundation presented the grant alongside Lt. Gov. Suzanne Crouch and Douglas Huntsinger, Executive Director for Drug Prevention, Treatment, & Enforcement for the State of Indiana and Chairman of the Indiana Commission to Combat Substance Use Disorder, to MHAI’s Indiana Recovery Network for their Regional Recovery Hub – Emergency Department Program. Read Full Press Release | View Photos
New Study on Stigmatizing Imagery for Substance Use Disorders Released A new Addiction Policy Forum-led study exploores stigmatizing and non-stigmatizing imagery for substance use disorders (SUD) and criminal justice contact. The qualitative study of people with lived experience with SUD identified stigmatizing images of substance use and criminal justice settings, along with alternative images to utilize. Researchers found that certain images were identified by individuals as not only stigmatizing but triggering, making individuals reactive and think of using again (i.e., relapse). Learn more
Biden administration moves to establish ‘guardrails’ for telehealth prescriptions The Biden administration has proposed new rules that will require patients to have an in-person medical evaluation before being prescribed most prescription medications by their doctors, with limited exceptions, according to a statement released on Friday. Learn more
Biden-Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States Xylazine’s growing role in overdose deaths nationwide prompts Administration to make this designation for the first time in U.S. history.
Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the United States. Xylazine is a non-opioid tranquilizer approved by the Food and Drug Administration (FDA) for veterinary use but not human use. This designation comes after careful review of the impact of xylazine on the opioid crisis, including its growing role in overdose deaths in every region of the United States. Learn more
